Title
Australian clinical toxicology investigators collaboration randomized trial of different loading infusion rates of N-acetylcysteine [6]
Document Type
Journal Article
RIS ID
62741
Abstract
Adverse reactions to N-acetylcysteine are reported in 6% to 23% of patients who are administered the antidote for treatment of paracetamol poisoning.1 Because paracetamol is the most common pharmaceutical product taken in overdose in many countries, it is essential that attempts be made to prevent or minimize adverse effects caused by N-acetylcysteine. We congratulate Kerr et al2 on their attempt to address this important issue.
COinS
This record is in the process of being updated. Please contact us for more information.
Publication Details
Gawarammana, I. B., Greene, S. L., Dargan, P. I. & Jones, A. L. (2006). Australian clinical toxicology investigators collaboration randomized trial of different loading infusion rates of N-acetylcysteine [6]. Annals of Emergency Medicine, 47 (1), 124.